| abstract |
The patent describes binding molecules that bind to both VEGF and Ang2, and methods for their preparation. In addition, there are described nucleic acids encoding these binding molecules, expression vectors containing these nucleic acids, host cells, a pharmaceutical composition containing at least one said binding molecule as an active substance and intended for the treatment of a disease associated with VEGF mediated and / or Ang2-mediated effects on angiogenesis. |